HYPERTROPHIC CARDIOMYOPATHY
Clinical trials for HYPERTROPHIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new HYPERTROPHIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for HYPERTROPHIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart drug tested in 500 chinese patients – Real-World results expected
Disease control Recruiting nowThis study looks at how well the drug mavacamten works for Chinese adults with a heart condition called obstructive hypertrophic cardiomyopathy. About 500 people will be followed in regular clinics to see if the drug improves heart function and symptoms. The goal is to understand…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
Gene therapy breakthrough targets inherited heart disease
Disease control Recruiting nowThis study tests a new gene therapy called TN-201 for people with a genetic form of hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens and makes it harder to pump blood. The therapy uses a harmless virus to deliver a working copy of the MYBPC3 gene dir…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE1, PHASE2 • Sponsor: Tenaya Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Heart drug HRS-1893 safety check: 300 patients monitored Long-Term
Disease control Recruiting nowThis study looks at the long-term safety of a drug called HRS-1893 in 300 people with hypertrophic cardiomyopathy, a condition where the heart muscle thickens. Participants must have taken HRS-1893 in a previous study. Researchers will track side effects and heart function over t…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Exercise may ease heart muscle disease symptoms, new study hopes to prove
Symptom relief Recruiting nowThis study looks at whether moderate exercise training can improve symptoms and heart function in people with hypertrophic cardiomyopathy, a condition where the heart muscle is thickened. About 70 adults aged 18 to 80 will be randomly assigned to either a moderate exercise progra…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC
-
New study tracks heart Drug's safety in pregnancy
Knowledge-focused Recruiting nowThis study monitors the safety of the heart medication mavacamten when taken during pregnancy or while breastfeeding. Researchers will track outcomes for mothers, fetuses, and infants up to one year after birth. The goal is to better understand any risks, not to test a new treatm…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Austria launches major heart muscle disease registry
Knowledge-focused Recruiting nowThis study is a registry that will collect information from about 1000 people with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened) across multiple clinics in Austria. Researchers will gather data from medical records, tests, and genetic testing to be…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
New registry aims to shed light on rare diseases
Knowledge-focused Recruiting nowThis study is creating a large database to collect information about people with rare diseases like amyloidosis, sarcoidosis, and many others. Researchers will track participants' health, treatments, and outcomes over time to better understand these conditions. The goal is to imp…
Matched conditions: HYPERTROPHIC CARDIOMYOPATHY
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC